Off-the-shelf, universal, macrophage reprogramming cell therapies for life-threatening diseases NASDAQ Ticker: ENLV The problem: The primary reason: The most prevalent life- Too many patients with life- threatening diseases involve threatening diseases do not multiple pathways of the immune respond to existing therapies system, making them highly evasive Sepsis is the 3rd leading cause of death in the U.S. and Europe There are currently no FDA/EMA approved drugs for the treatment of sepsis United States Eur ...